Loading…
Fierce Biotech Next Gen 2022 has ended
Thursday, June 30 • 11:10am - 11:30am
Executive Interview: Max Lataillade, Vice President, Head of Global Research Strategy, ViiV Healthcare

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Moderators
avatar for Annalee Armstrong

Annalee Armstrong

Senior Editor, Fierce Biotech
Annalee Armstrong is a senior editor for Fierce Biotech. Prior to joining Fierce in April 2021, Annalee was an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she was the EPA reporter covering climate and energy policy on the Hill in Washington... Read More →

Speakers
avatar for Max Lataillade

Max Lataillade

Vice President, Head of Global Research Strategy, ViiV Healthcare
Max Lataillade is responsible for global research and development strategy for the HIV pipeline at ViiV Healthcare, the only company 100% dedicated to HIV. He oversees end-to-end R&D activities for all novel HIV pipeline programs designed to address key unmet medical needs for people... Read More →


Thursday June 30, 2022 11:10am - 11:30am EDT